This finding aligns with previous research on NIPP effects in different cancer entities as well as other reports on different breast cancer therapies, such as radiotherapy, paclitaxel, and Olaparib, which similarly activate the STING pathway through DNA damage (22–24, 36). The gene discussed is STING1; the disease is breast cancer.